Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (7400)	12/4/2002 11:52:17 AM
From: Sam Citron	Read Replies (1) \| Respond to of 52153

a little later after FDA approval, it becomes primarily a question of projecting peak sales and speed of ramp up. I would argue that this is much easier to project than anything in the silicon-based area - there is no issue of cyclical demand, no link to the rest of the economy, no issue of substantial pricing weakness or new competition or product life cycles for the next several years. Easier said than done. <g> Perhaps you could give a demonstration of such an analysis leading to a concrete purchase decision with a price target attached.